Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 02, 2023

High-Dose Melphalan Treatment Increases Mutational Burden at Relapse in Patients With Multiple Myeloma



Additional Info

Disclosure statements are available on the authors' profiles:

High-Dose Melphalan Treatment Significantly Increases Mutational Burden at Relapse in Multiple Myeloma
Blood 2023 Jan 05;[EPub Ahead of Print], MK Samur, M Roncador, A Aktas Samur, M Fulciniti, AH Bazarbachi, RE Szalat, MA Shammas, AS Sperling, PG Richardson, F Magrangeas, S Minvielle, A Perrot, J Corre, P Moreau, A Thakurta, G Parmigiani, KC Anderson, H Avet-Loiseau, NC Munshi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading